Quest Laboratories share price
NSE: QUESTLABPharmaceuticals & Biotechnology
Quest Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2024 · Issue price ₹97
Last close ₹81.95down ₹2.05 (2.44%)
Share price at the NSE close on 27 Oct 2026. Previous close ₹84.00.
27 Oct: open ₹82.00, high ₹84.00, low ₹81.95
52-week range of traded prices to 27 Oct 2026
₹68.60Low, 21 Sep 2026₹152.60High, 30 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹134 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 93,60098.7% delivered
Results
Standalone; ₹ crore.Quest Laboratories quarterly results
Quarter to Mar 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹32 Crup 5.85%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹2.87 Crdown 28.70%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.9%
Revenue by quarter
Peak revenue ₹32 Cr, quarter to Mar 2026; lowest ₹23 Cr, quarter to Jun 2025
Net profit by quarter, a loss in red
| ₹ crore | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 23.2 | 25.6 | 30.6 | 32.4 |
| Net profit | 4.1 | 4.0 | 4.0 | 2.9 |
| Net margin | 17.7% | 15.7% | 13.2% | 8.9% |
Standalone. The 4 quarters from Jun 2025, the first on record; the half years before them are below. The latest is shaded.
| ₹ crore | Sep 2024 |
|---|---|
| Revenue | 42.6 |
| Net profit | 8.0 |
| Net margin | 18.8% |
Standalone. The half years in the same span that the quarters on record do not fully cover.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹112 Crup 7.61%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹15 Crup 10.71%
- Net margin
- 13.4%
Revenue by year
Peak revenue ₹112 Cr, year to Mar 2026; lowest ₹83 Cr, year to Mar 2024
Net profit by year, a loss in red
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 83 | 104 | 112 |
| Net profit | 10 | 14 | 15 |
| Net margin | 12.2% | 13.1% | 13.4% |
Standalone. Years to March. The latest is shaded.
Business segments
In the year to Mar 2026 the company reports one business segment, wise reporting as defined in Ind-as 108 is not applicable, since the entire operation of the company relates to only one segment, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +1.9% | +10.6% | −7.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.
Quest Laboratories competitors and peers
Pharmaceuticals, 216 listed companies, priced on 27 Oct 2026. The table lists the 8 companies closest to Quest Laboratories in market cap.Healthcare companies
Quest Laboratories is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Curis LifesciencesCURIS | 146 | 21.04 | 3.07 | – | – | 14.6% | 15.1% | 0.00% |
 Auro LaboratoriesAUROLAB | 142 | 30.21 | 3.05 | +125.5% | – | 10.5% | 8.8% | 0.00% |
 Panchsheel OrganicPANCHSHEEL | 135 | 13.14 | 0.96 | +2.3% | – | 7.5% | 7.3% | 3.12% |
 Par Drugs and ChemicalsPAR | 135 | 9.30 | 1.20 | +4.3% | +2.4% | 13.7% | 14.5% | 0.00% |
 Bal PharmaBALPHARMA | 132 | 18.35 | 1.61 | +13.5% | +1.3% | 9.0% | 9.3% | 1.45% |
 Krebs Biochemicals and IndustriesKREBSBIO | 129 | – | – | −29.7% | – | – | −14.4% | 0.00% |
 Lactose (India)LACTOSE | 128 | 18.46 | 1.97 | +34.9% | +57.8% | 11.2% | 10.6% | 0.00% |
 Speciality MedicinesSPML | 124 | 9.51 | 1.74 | – | – | 18.3% | – | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Quest Laboratories announcements
Oct 2026
Sep 2026
30 Sep · Meeting
29 Sep · Updates
29 Sep · Updates
29 Sep · Updates
Quest Laboratories share price by year
Each calendar year to 2025.Quest Laboratories share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 110.10 | −9.0% | 158.70 | 81.50 |
| 2024 | 121.05 | – | 178.95 | 85.55 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2024 is from its first session, 23 May 2024.
Recent sessions
The 9 trading days to 26 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 26 Oct 2026 | 81.95 | 84.00 | 81.95 | 84.00 | 83.49 | 9,600 | 100.0% |
| 23 Oct 2026 | 88.10 | 89.75 | 81.10 | 82.00 | 86.20 | 12,000 | 90.0% |
| 22 Oct 2026 | 90.20 | 90.20 | 87.40 | 87.40 | 88.81 | 4,800 | 75.0% |
| 21 Oct 2026 | 90.25 | 90.25 | 90.20 | 90.20 | 90.21 | 10,800 | 100.0% |
| 19 Oct 2026 | 90.20 | 90.20 | 90.20 | 90.20 | 90.20 | 1,200 | 100.0% |
| 16 Oct 2026 | 91.20 | 93.00 | 90.00 | 92.20 | 91.22 | 13,200 | 72.7% |
| 15 Oct 2026 | 94.05 | 94.05 | 94.00 | 94.00 | 94.03 | 2,400 | 100.0% |
| 14 Oct 2026 | 94.00 | 94.25 | 94.00 | 94.00 | 94.12 | 4,800 | 75.0% |
| 13 Oct 2026 | 95.50 | 98.00 | 95.00 | 97.20 | 96.37 | 24,000 | 90.0% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- QUESTLAB
- ISIN
- INE0TNW01017
- Industry
- Pharmaceuticals & Biotechnology